Literature DB >> 30902563

Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy.

Wei-Di Yu1, Guan Sun2, Jun Li3, Jiang Xu4, Xiaochen Wang5.   

Abstract

Immunotherapies based on T cells have gained significant success in the treatment of diverse cancers, however, several limitations also exist, including low response, acquired resistance and severe side effects, which lead to unfavorable outcomes. Recent studies found that traditional therapies, radiotherapy and/or chemotherapy may affect the immune condition in situ and cause abscopal effect, which may improve the response of immunotherapies, enhance the efficiency, and reduce the untoward effect. Here, we review the mechanisms uncovering the cancer immunotherapy and immunogenic effects of radiotherapy and chemotherapy, aiming to highlight the principles underlying the therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy and ultimately guide better designs for future synergistic cancer therapies.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer immunity; Chemotherapy; Immunotherapy; Radiotherapy

Year:  2019        PMID: 30902563     DOI: 10.1016/j.canlet.2019.02.048

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  35 in total

Review 1.  Immune-based therapies in penile cancer.

Authors:  Vidhu B Joshi; Philippe E Spiess; Andrea Necchi; Curtis A Pettaway; Jad Chahoud
Journal:  Nat Rev Urol       Date:  2022-07-18       Impact factor: 16.430

Review 2.  Regulated cell death (RCD) in cancer: key pathways and targeted therapies.

Authors:  Fu Peng; Minru Liao; Rui Qin; Shiou Zhu; Cheng Peng; Leilei Fu; Yi Chen; Bo Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

3.  Treatment of Multiple Primary Malignancies With PD-1 Inhibitor Camrelizumab: A Case Report and Brief Literature Review.

Authors:  Yuchen Wan; Zhixue Wang; Ning Yang; Fenye Liu
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

Review 4.  Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy.

Authors:  Bashdar Mahmud Hussen; Goran Sedeeq Hama Faraj; Mohammad Fatih Rasul; Hazha Jamal Hidayat; Abbas Salihi; Aria Baniahmad; Mohammad Taheri; Soudeh Ghafouri-Frad
Journal:  Cancer Cell Int       Date:  2022-10-18       Impact factor: 6.429

Review 5.  Exosome-based immunotherapy: a promising approach for cancer treatment.

Authors:  Zhijie Xu; Shuangshuang Zeng; Zhicheng Gong; Yuanliang Yan
Journal:  Mol Cancer       Date:  2020-11-12       Impact factor: 27.401

6.  Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy.

Authors:  Nancy D Ebelt; Edith Zuniga; Monica Marzagalli; Vic Zamloot; Bruce R Blazar; Ravi Salgia; Edwin R Manuel
Journal:  Biomedicines       Date:  2020-12-16

7.  Circulating immune cell populations related to primary breast cancer, surgical removal, and radiotherapy revealed by flow cytometry analysis.

Authors:  Alessandra Franzetti Pellanda; Curzio Rüegg; Sarah Cattin; Benoît Fellay; Antonello Calderoni; Alexandre Christinat; Laura Negretti; Maira Biggiogero; Alberto Badellino; Anne-Lise Schneider; Pelagia Tsoutsou
Journal:  Breast Cancer Res       Date:  2021-06-05       Impact factor: 6.466

Review 8.  Recent advances on microneedle arrays-mediated technology in cancer diagnosis and therapy.

Authors:  Vahid Alimardani; Samira Sadat Abolmaali; Ali Mohammad Tamaddon; Mohammad Ashfaq
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

9.  Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) study.

Authors:  Ornella Garrone; Andrea Michelotti; Matteo Paccagnella; Filippo Montemurro; Anna Maria Vandone; Andrea Abbona; Elena Geuna; Paola Vanella; Claudia De Angelis; Cristiana Lo Nigro; Antonella Falletta; Nicola Crosetto; Massimo Di Maio; Marco Merlano
Journal:  ESMO Open       Date:  2020-10

10.  Identification and validation of a miRNA-related expression signature for tumor mutational burden in colorectal cancer.

Authors:  Lijun Xu; Qing Zheng
Journal:  World J Surg Oncol       Date:  2021-02-20       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.